# Wei Deng

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wei-deng/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,519 |
| Field | Esophageal Cancer Research and Treatment |
| h-index | 29 |
| i10-index | 54 |
| Last Known Institution | Guangzhou University of Chinese Medicine |
| OpenAlex ID | https://openalex.org/A5030238533 |
| ORCID iD | 0000-0003-1778-2013 |
| Works | 152 |

## Researcher papers

- [SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis](https://scholariq.org/papers/simplify-1-a-phase-iii-randomized-trial-of-momelotinib-versus-ruxolitinib-in/)
- [Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)](https://scholariq.org/papers/phase-ii-evaluation-of-nivolumab-in-the-treatment-of-persistent-or-recurrent/)
- [The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy](https://scholariq.org/papers/the-relationship-of-lymphocyte-recovery-and-prognosis-of-esophageal-cancer/)
- [Long‐term safety and efficacy of deferasirox (Exjade<sup>®</sup>) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease](https://scholariq.org/papers/long-term-safety-and-efficacy-of-deferasirox-exjade-sup-sup-for-up-to-5-years-in/)
- [Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future](https://scholariq.org/papers/ferroptosis-mechanisms-and-regulations-in-cardiovascular-diseases-in-the-past/)
- [A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix](https://scholariq.org/papers/a-phase-i-ii-evaluation-of-veliparib-nsc-737664-topotecan-and-filgrastim-or/)
- [Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram](https://scholariq.org/papers/prediction-of-severe-lymphopenia-during-chemoradiation-therapy-for-esophageal/)
- [A Critical Review of LET-Based Intensity-Modulated Proton Therapy Plan Evaluation and Optimization for Head and Neck Cancer Management](https://scholariq.org/papers/a-critical-review-of-let-based-intensity-modulated-proton-therapy-plan/)
- [The effect of vitamin D supplementation on knee osteoarthritis: A meta-analysis of randomized controlled trials](https://scholariq.org/papers/the-effect-of-vitamin-d-supplementation-on-knee-osteoarthritis-a-meta-analysis/)
- [Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218](https://scholariq.org/papers/predictive-blood-based-biomarkers-in-patients-with-epithelial-ovarian-cancer/)
- [Gender-related differences in clinicopathological characteristics and renal outcomes of Chinese patients with IgA nephropathy](https://scholariq.org/papers/gender-related-differences-in-clinicopathological-characteristics-and-renal/)

## Researcher topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

## Researcher university

- [Guangzhou University of Chinese Medicine](https://scholariq.org/institutions/guangzhou-university-of-chinese-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.